Citation Impact
Citing Papers
Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma
2014 Standout
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
2012 Standout
Transient Ablation of Regulatory T cells Improves Antitumor Immunity in Colitis-Associated Colon Cancer
2014 StandoutNobel
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Endoscopy in Inflammatory Bowel Disease
2007
The gut microbiota and host health: a new clinical frontier
2015 Standout
Chromoscopy-Guided Endomicroscopy Increases the Diagnostic Yield of Intraepithelial Neoplasia in Ulcerative Colitis
2007
Cytokines in inflammatory bowel disease
2014 Standout
Mucosal Dysplasia in Ileal Pelvic Pouches After Restorative Proctocolectomy
2007
Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis
2003
Cancer in inflammatory bowel disease
2008
Hepatocellular carcinoma
2003 Standout
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial
2006 Standout
Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?
2000
High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: An indication for salvage liver transplantation
2004
Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohnʼs disease of the colon
2008
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
2001 Standout
CXCR1‐binding chemokines in inflammatory bowel diseases: down‐regulated IL‐8/CXCL8 production by leukocytes in Crohn's disease and selective GCP‐2/CXCL6 expression in inflamed intestinal tissue
2004
Gross Versus Microscopic Pancolitis and the Occurrence of Neoplasia in Ulcerative Colitis
2003
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
2002 Standout
Risk Factors for Colorectal Neoplasia in Inflammatory Bowel Disease: A Nested Case?Control Study From Copenhagen County, Denmark and Olmsted County, Minnesota
2007
Hepatocellular carcinoma
2016 Standout
Contemporary Morphologic Definition of Backwash Ileitis in Ulcerative Colitis and Features That Distinguish It From Crohn Disease
2006
Ulcerative Colitis
2011 Standout
Long-term outcome 10 years or more after restorative proctocolectomy and ileal pouch–anal anastomosis in patients with ulcerative colitis
2009
Liver fibrosis – from bench to bedside
2003 Standout
AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease
2010
LIVING-DONOR VERSUS CADAVERIC LIVER TRANSPLANTATION FOR NON-RESECTABLE SMALL HEPATOCELLULAR CARCINOMA AND COMPENSATED CIRRHOSIS: A DECISION ANALYSIS1
2001
Guidelines for the management of inflammatory bowel disease in adults
2011
Locoregional Therapy With Curative Intent Versus Primary Liver Transplant for Hepatocellular Carcinoma
2017
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Crohn's disease
2012 Standout
A Proposed Classification of Ileal Pouch Disorders and Associated Complications After Restorative Proctocolectomy
2008
Hepatocellular carcinoma
2012 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Diagnosis and management of pouchitis1 1Abbreviations used in this paper: EIM, extraintestinal manifestations; FAP, familial adenomatous polyposis; IL, interleukin; IPAA, ileal pouch anal anastomosis; pANCA, serum antineutrophil cytoplasmic antibody-perinuclear staining pattern; PAS, Pouchitis Activity Score; PDAI, Pouchitis Disease Activity Index; PSC, primary sclerosing cholangitis; QOL, quality of life; SCFA, small chain fatty acids.
2003
Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow
2003
Ulcerative colitis
2002
Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases
2004 Standout
The Effect of Ageing on Function and Quality of Life in Ileal Pouch Patients
2004
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Revolution and evolution: 30 years of ileoanal pouch surgery
2006
Hepatocellular carcinoma: Diagnosis and treatment
2002
Management of Hepatocellular Carcinoma *
2005 Standout
Activation-Induced Cytidine Deaminase Links Between Inflammation and the Development of Colitis-Associated Colorectal Cancers
2008 StandoutNobel
Adenocarcinoma following ileal pouch–anal anastomosis for ulcerative colitis: Review of 26 cases
2008
Validation of an extension of the international non‐invasive criteria for the diagnosis of hepatocellular carcinoma to the characterization of macroscopic portal vein thrombosis
2010
Inflammation and Colon Cancer
2010 Standout
Pouchitis: What Every Gastroenterologist Needs to Know
2013
From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation
2004
Ulcerative colitis
2012 Standout
Preoperative Predictors of Survival After Resection of Small Hepatocellular Carcinomas
2002
Crohn's disease
2016 Standout
Radiofrequency Ablation of Hepatocellular Cancer in 110 Patients With Cirrhosis
2000
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Comparison of Outcomes After Restorative Proctocolectomy With or Without Defunctioning Ileostomy
2008
Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence-based analysis of 15 years of experience
2011
Predictive and Protective Factors Associated With Colorectal Cancer in Ulcerative Colitis: A Case-Control Study
2006
Risk of dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis
2006
Chronic hepatitis B
2007 Standout
Clinical guidelines for the management of pouchitis
2009
Severe anaphylactic reaction to infliximab
2004
Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma
2001
Endoscopy in inflammatory bowel disease
2002
Chronic hepatitis B: Update 2009 #
2009 Standout
European evidence-based Consensus on the management of ulcerative colitis: Special situations
2008
Pathologic Features and Clinical Significance of ???Backwash??? Ileitis in Ulcerative Colitis
2005
CCL25/CCR9 Interactions Regulate Large Intestinal Inflammation in a Murine Model of Acute Colitis
2011
A Prospective Multivariate Analysis of Clinical Factors Associated With Pouchitis After Ileal Pouch–Anal Anastomosis
2007
ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease
2006
Results and Complications after Ileal Pouch Anal Anastomosis: A Meta-Analysis of 43 Observational Studies Comprising 9,317 Patients
2005
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
2012
Ulcerative colitis
2016 Standout
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Eicosanoids and cancer
2010 Standout
Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk
2004
Diagnosis and management of dysplasia in patients with inflammatory bowel diseases
2004
Azathioprine or 6-Mercaptopurine Before Colectomy for Ulcerative Colitis Is Not Associated With Increased Postoperative Complications
2002
Pouchitis and Pouch Dysfunction
2009
Blockade of Leukotriene B4 Signaling Pathway Induces Apoptosis and Suppresses Cell Proliferation in Colon Cancer
2007
Quality of life after restorative proctocolectomy for ulcerative colitis: Preoperative status and long-term results
2007
Diagnostic difficulties in inflammatory bowel disease pathology
2005
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
2014 Standout
Difference in Tumor Invasiveness in Cirrhotic Patients With Hepatocellular Carcinoma Fulfilling the Milan Criteria Treated by Resection and Transplantation
2006
Hepatocellular Carcinoma
2011 Standout
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus–related cirrhosis
2005
Surgical Management of Early-Stage Hepatocellular Carcinoma: Resection or Transplantation?
2008
Subtotal Colectomy for Severe Acute Colitis: A 20-Year Experience of a Tertiary Care Center with an Aggressive and Early Surgical Policy
2003
A flexible and highly sensitive strain-gauge sensor using reversible interlocking of nanofibres
2012 Standout
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
Peripheral and Intestinal Regulatory CD4+CD25high T Cells in Inflammatory Bowel Disease
2005
Differentiating Ulcerative Colitis from Crohn Disease in Children and Young Adults: Report of a Working Group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America
2007
CD44 cell adhesion molecules.
1999
Comparison of Percutaneous Acetic Acid Injection and Percutaneous Ethanol Injection for Hepatocellular Carcinoma in Cirrhotic Patients: A Prospective Study
2003
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
Inflammatory Bowel Disease
2010 Standout
Treatment of Hepatocellular Carcinoma Associated with Cirrhosis in the Era of Liver Transplantation
1998
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategies
2008
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Long-Term Survival and Pattern of Recurrence After Resection of Small Hepatocellular Carcinoma in Patients With Preserved Liver Function
2002
Liver Transplantation for Malignancy
2005
Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
2009
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
An Increased Expression of Cysteinyl Leukotriene 2 Receptor in Colorectal Adenocarcinomas Correlates with High Differentiation
2007
European evidence-based Consensus on the management of ulcerative colitis: Current management
2008
Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis
2006 StandoutNobel
Works of U. Heuschen being referenced
Diagnosing Pouchitis
2002
Adenocarcinoma in the ileal pouch: late risk of cancer after restorative proctocolectomy
2001
No evidence for cancer-related CD44 splice variants in primary and metastatic colorectal cancer
1998
Risk Factors for Ileoanal J Pouch-Related Septic Complications in Ulcerative Colitis and Familial Adenomatous Polyposis
2002
Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease
2002
Differential expression of toll-like receptor 3 and 5 in ileal pouch mucosa of ulcerative colitis patients
2006
Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis
2001
Long-term follow-up after ileoanal pouch procedure
2001
Survival and Recurrence After Liver Transplantation Versus Liver Resection for Hepatocellular Carcinoma
1998
Prä- und postoperative Lebensqualität von Patienten mit Colitis ulcerosa und familiärer adenomatöser Polyposis bei ileoanaler Pouchoperation
1998
Is transplantation really superior to resection in the treatment of small hepatocellular carcinoma?
1997
Chirurgische Therapie der Colitis ulcerosa im Kindesalter
2004
Lebensqualität im Langzeitverlauf nach kontinenzerhaltender Proktocolektomie wegen Colitis ulcerosa und familiärer adenomatöser Polyposis
1998
[Technique and results of the ileoanal pouch after proctocolectomy].
1994
One- or Two-stage Procedure for Restorative Proctocolectomy
2001
Outcome after septic complications in J pouch procedures
2002